In vitro fertilization (IVF) is a costly procedure, with a single cycle potentially reaching tens of thousands of dollars. For many, this significant expense does not guarantee a successful outcome. Some patients, however, may receive a refund if their cycle fails, thanks to specific financial programs.

Financial Barriers in IVF

Cost is a substantial challenge for prospective parents considering IVF. Insurance often doesn’t cover IVF or related medications. As a result, many Americans incur debt while striving to become parents. Numerous individuals undergo multiple cycles, sometimes ending in disappointment and financial strain.

Introduction of Shared Risk Programs

A shared risk program offers patients a partial refund if IVF procedures fail. These programs charge around 30-40% more than a single IVF cycle. If a patient becomes pregnant on the first attempt, they may pay more than the actual cost of treatment due to sharing the risk.

Shared risk programs are sometimes referred to as refund programs or money-back IVF plans. They require a higher upfront payment covering multiple IVF attempts, rather than individual cycle payments.

Under these plans, patients typically pay a flat fee that encompasses two to six IVF cycles and related embryo transfers. A live birth during the program means the clinic retains the payment. If no live birth occurs after all attempts, patients might receive a refund of 70% to 100% of the initial fee, depending on program specifics.

Considerations Before Enrolling

Patients should thoroughly understand what the shared risk agreement includes and excludes. Elana Frank, CEO of the Jewish Fertility Foundation, emphasizes the importance of knowing which expenses are covered, the number of retrievals and transfers included, and the program’s definition of success. Patients should also consider the financial commitment and potential for more overall expense if they succeed on an early cycle.

Qualification Criteria

Not everyone qualifies for shared risk programs. Enrollees undergo extensive screening based on factors like age, ovarian reserve, health, body mass index, and fertility treatment history. Clinics prefer participants with a favorable prognosis to maintain financial viability. Typically, these programs are open to younger women, such as those under 38 or 40, and exclude those with less promising prognoses.

Financial Impact of IVF

The high cost of IVF deters many from pursuing it. A single cycle usually costs between $12,000 and $25,000, excluding extras like medications, genetic testing, and storage fees. Complete cycles, including all services, can exceed $30,000. Affordability significantly influences the utilization of fertility treatments. Countries with lower out-of-pocket costs report higher rates of births from assisted reproductive technologies.

Insurance and Accessibility

Insurance coverage varies widely and is often limited. Though fertility coverage has improved, gaps remain. Refund programs offer financial predictability, yet they do not reduce treatment costs. More expansive access calls for lowering costs further, a goal partly achieved through policy changes lowering medication expenses. Advocacy for broader employer-sponsored fertility benefits could provide better support.

However, freelancers, contractors, and small business employees may still lack coverage. Many existing financial options are reactive, leaving patients to manage substantial out-of-pocket costs upon facing fertility treatments.

Success Rates of IVF

IVF success hinges on various factors: age, embryo quality, health, and infertility causes. Younger patients have higher success rates, while egg quality declines with age. Recent advances in reproductive medicine have improved outcomes, although IVF is no guarantee. With increased egg freezing cycles, expectations around IVF should be tempered.

IVF involves a series of complex, emotionally demanding steps, including hormone injections and monitoring. Repeated failures challenge patients, financially and emotionally, influencing whether shared risk plans are worthwhile. For some, their financial investment may not align with their prognosis, making traditional pay-per-cycle methods more suitable.